Current Ratio in % of Checkpoint Therapeutics, Inc. from Q2 2017 to Q1 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Checkpoint Therapeutics, Inc. quarterly Current Ratio history and change rate from Q2 2017 to Q1 2025.
Checkpoint Therapeutics, Inc. Current Ratio for the quarter ending 31 Mar 2025 was 68 %, a 128% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Checkpoint Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q1 2025	68	+38.2	+128%	31 Mar 2025
Q4 2024	37.2	+15.2	+69.2%	31 Dec 2024
Q3 2024	35.3	+9.17	+35.1%	30 Sep 2024
Q2 2024	30.3	-12.3	-28.9%	30 Jun 2024
Q1 2024	29.8	-37.4	-55.6%	31 Mar 2024
Q4 2023	22	-84.7	-79.4%	31 Dec 2023
Q3 2023	26.2	-132	-83.5%	30 Sep 2023
Q2 2023	42.6	-180	-80.8%	30 Jun 2023
Q1 2023	67.2	-251	-78.9%	31 Mar 2023
Q4 2022	107	-334	-75.8%	31 Dec 2022
Q3 2022	158	-471	-74.9%	30 Sep 2022
Q2 2022	222	-484	-68.5%	30 Jun 2022
Q1 2022	318	-274	-46.2%	31 Mar 2022
Q4 2021	440	-22.6	-4.88%	31 Dec 2021
Q3 2021	629	+234	+59.3%	30 Sep 2021
Q2 2021	706	+422	+149%	30 Jun 2021
Q1 2021	592	+335	+130%	31 Mar 2021
Q4 2020	463	+240	+108%	31 Dec 2020
Q3 2020	395	+208	+111%	30 Sep 2020
Q2 2020	284	+57.6	+25.4%	30 Jun 2020
Q1 2020	257	-15.1	-5.55%	31 Mar 2020
Q4 2019	223	-113	-33.7%	31 Dec 2019
Q3 2019	187	-214	-53.3%	30 Sep 2019
Q2 2019	226	-200	-46.9%	30 Jun 2019
Q1 2019	272	-199	-42.3%	31 Mar 2019
Q4 2018	336	-194	-36.6%	31 Dec 2018
Q3 2018	401	-290	-41.9%	30 Sep 2018
Q2 2018	426	-408	-49%	30 Jun 2018
Q1 2018	471			31 Mar 2018
Q4 2017	529			31 Dec 2017
Q3 2017	690			30 Sep 2017
Q2 2017	834			30 Jun 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.